查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016939

尿失禁治療設備市場：按設備類型、材料、技術、性別、外形、年齡層、應用、最終用戶和分銷管道分類 - 全球市場預測（2026-2032 年）

Urinary Incontinence Device Market by Device Type, Material, Technology, Gender, Form, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，尿失禁設備市場價值將達到 40.1 億美元，到 2026 年將成長至 42.3 億美元，到 2032 年將達到 64.5 億美元，複合年成長率為 7.03%。

主要市場統計數據
基準年（2025 年） 40.1億美元
預計年份（2026年） 42.3億美元
預測年份（2032年） 64.5億美元
複合年成長率 (%) 7.03%

為尿失禁設備領域的相關人員提供策略框架，以指導他們了解未滿足的臨床需求、不斷變化的患者期​​望和跨學科優先事項。

本執行摘要重點介紹尿失禁治療裝置的現狀，著重闡述其臨床負擔、不斷變化的患者期​​望以及應指導相關人員的策略重點。由於尿失禁不分年齡和性別，且臨床表現多樣，因此需要採用結合保守治療、微創治療和植入式治療的綜合方法。在所有治療方案中，臨床醫生都力求找到兼顧療效、病患舒適度和長期耐用性的裝置，而採購負責人和保險公司等相關人員則越來越重視可驗證的療效和成本效益。

技術、人口和監管方面的變革正在重新定義尿失禁設備的競爭優勢和部署途徑。

受技術、人口結構和政策等多面向因素的影響，尿失禁治療器材市場格局正經歷著變革性的變化。電刺激技術的進步、植入材料的改進以及機械部件的小型化，在提升器械性能的同時，也提高了患者的舒適度。同時，遠距監測的普及以及與行動醫療平台的整合，使得長期追蹤治療依從性、了解真實世界療效成為可能，這也為基於循證醫學的醫保報銷機制的討論提供了支持。

2025 年實施的關稅政策變化將如何重塑尿失禁設備整個價值鏈的採購、籌資策略和商業化趨勢？

美國2025年實施的關稅調整的累積影響將對尿失禁醫療器材生態系統產生重大影響，尤其是對那些依賴跨境供應鏈採購零件、成品或特殊材料的製造商而言。關稅負擔的增加可能導致投入成本上升，並擠壓製造商的利潤空間，促使他們重新評估籌資策略。為此，採購團隊可能會採取近岸外包、雙重採購以及重新談判供應商合約等措施，以降低風險並維持獲利能力。

將醫療設備類型、材料選擇、技術模式、患者人口統計特徵和分銷管道與臨床引入和商業策略聯繫起來的綜合細分洞察。

關鍵的市場細分洞察揭示了產品設計、材料科學、技術模式、目標受眾、使用模式和管道偏好如何相互交織，共同塑造臨床應用和商業性機會。醫療設備依類型分類時，市場可分為「體外器材」及「體內器材」。體外器械包括導管、集液器、輸液集液器和陰莖夾，而體內器械包括人工尿道括約肌、子宮托、薦骨神經刺激器、尿道植入物和陰道吊帶。就材料選擇而言，乳膠仍然是重要的組成部分，此外還有聚合物和矽膠。每種材料對生物相容性、患者舒適度和生產過程的影響各不相同。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢正在決定監管策略、報銷方案的調整以及分銷重點。

區域趨勢對監管環境、報銷系統和供應鏈結構產生顯著影響，進而影響企業如何確定投資優先順序和製定打入市場策略。在美洲，市場參與企業面臨著不同的支付方環境和高度專業化的臨床環境，通常需要清晰的療效數據、與關鍵意見領袖 (KOL) 的有針對性的合作以及彈性價格設定框架。在歐洲、中東和非洲，相關人員則面臨著複雜的監管要求和報銷標準，其中各國特定的核准流程和在地化的臨床證據在產品推廣中發揮著至關重要的作用。在這些地區的許多地方，與當地經銷商建立合作關係以及對採購週期進行精心管理是成功進入市場的關鍵。

尿失禁治療領域的領導地位發展軌跡，以及塑造長期差異化的競爭、夥伴關係模式與創新管道。

在產品創新、策略夥伴關係和差異化商業模式的驅動下，泌尿道失禁醫療器材產業的競爭動態持續演變。主要企業正投資於模組化設計策略，以實現迭代改進，同時保持監管的連續性。醫療器材製造商與數位醫療服務提供者之間的合作正在加速整合解決方案的開發，這些解決方案將機械或​​植入式治療與遠端監測和藥物依從性管理平台相結合，從而增強了對支付方和醫療服務提供者的價值提案。

設備開發商和商業化團隊的實際優先事項，透過整合產品設計、證據產生和供應彈性，確保永續的競爭優勢。

產業領導企業應制定一系列切實可行的優先事項，將產品設計、臨床檢驗、商業性執行和供應鏈韌性有機結合，以實現永續的競爭優勢。首先，優先考慮以可製造性為導向的設計和以使用者為中心的人體工學，以降低整體擁有成本，同時提高患者依從性和臨床醫生的接受度。其次，將可靠的真實世界證據計畫融入產品生命週期，以支持健保報銷談判，並在不同的醫療環境中展示長期療效。第三，實現供應商多元化，並考慮將關鍵零件的生產外包到近岸地區，以降低關稅風險和物流中斷的影響。

我們嚴謹的混合方法研究途徑，結合對關鍵相關人員的訪談、臨床文獻的整合以及透過三角測量進行證據檢驗，為策略決策提供依據。

本執行摘要的調查方法結合了對原始臨床文獻的結構化回顧、對關鍵臨床和商業相關人員的定性訪談，以及對監管和政策趨勢的系統分析。關鍵資訊來源包括與泌尿系統和婦科醫生、醫院和長期護理網路的採購經理以及產品開發專家的深入對話，以確保結論能夠反映技術、臨床和商業性觀點。輔助分析納入了同行評審期刊、監管指導文件、產品標籤以及公司發布的臨床試驗摘要，檢驗有關臨床表現的說明。

一項具有前瞻性的綜合分析，強調創新、證據產生和供應彈性之間的策略協調，以最大限度地提高患者獲益和商業性成功。

總之，尿失禁治療器材領域正處於一個轉折點，技術進步、支付方期望的改變以及供應鏈重組交織在一起，既帶來了挑戰，也帶來了機會。那些能夠將產品創新與切實可行的循證策略、完善的採購體係以及區域最佳化的實施計劃相結合的公司，將更有能力將臨床能力轉化為對患者的實際益處。臨床、監管和商業團隊之間的跨部門合作對於克服器材在不同醫療環境中部署和廣泛應用所面臨的複雜挑戰至關重要。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：美國關稅的累積影響（2025 年）

第7章：人工智慧（AI）的累積影響（2025 年）

第8章：尿失禁器械市場：依器械類型分類

  • 體外裝置
    • 導管
    • 收藏家/滴漏收藏家
    • 陰莖夾
  • 內部裝置
    • 人工尿道括約肌
    • 子宮托
    • 薦骨神經刺激器
    • 尿道插入器
    • 陰道吊帶

第9章 尿失禁器材市場：依材料分類

  • 乳膠
  • 聚合物基材料
  • 矽酮

第10章 尿失禁治療設備市場：依技術分類

  • 電刺激設備
  • 機械裝置
  • 外科植入

第11章 尿失禁器材市場：性別

  • 女士
  • 男性

第12章 尿失禁治療器材市場：依形式分類

  • 一次性
  • 可重複使用類型

第13章：尿失禁器械市場：依年齡層別分類

  • 成人版
  • 適合兒童

第14章 尿失禁器械市場：依應用領域分類

  • 功能性尿失禁
  • 溢出性尿失禁
  • 應力性尿失禁
  • 急性尿失禁

第15章：尿失禁設備市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院和診所
  • 長期照護機構

第16章：尿失禁治療設備市場：依通路分類

  • 離線
  • 線上

第17章 尿失禁治療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第18章：尿失禁器材市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第19章：尿失禁器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第20章：美國尿失禁醫療器材市場

第21章：中國尿失禁醫療器材市場

第22章 競爭情勢

  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）
  • Aeroflow Inc.
  • Amber Therapeutics
  • Attends Healthcare Products, Inc. by Domtar Corporation
  • Avanos Medical, Inc.
  • Avation Medical
  • B. Braun SE
  • Becton, Dickinson and Company
  • BioDerm, Inc.
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast A/S
  • Contipi Medical
  • ConvaTec Group PLC
  • Essity AB
  • Hollister Incorporated
  • Johnson & Johnson Services Inc.
  • Kimberly-Clark Corporation
  • Laborie
  • Life360 Innovation, Inc.
  • Medtronic PLC
  • Olympus Corporation
  • Ontex Group NV
  • Pelvital USA Inc.
  • PROMEDON GmbH
  • Styker Corporation
  • Teleflex Incorporated
  • Watkins-Conti Products, Inc.
Product Code: MRR-034B50030353

The Urinary Incontinence Device Market was valued at USD 4.01 billion in 2025 and is projected to grow to USD 4.23 billion in 2026, with a CAGR of 7.03%, reaching USD 6.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.01 billion
Estimated Year [2026] USD 4.23 billion
Forecast Year [2032] USD 6.45 billion
CAGR (%) 7.03%

A strategic framing of clinical unmet needs, evolving patient expectations, and the multidisciplinary priorities that should guide urinary incontinence device stakeholders

This executive summary opens with a focused introduction to the urinary incontinence device landscape, emphasizing the clinical burden, evolving patient expectations, and the strategic priorities that should guide industry stakeholders. The condition transcends age and gender boundaries, creating heterogeneous clinical presentations that demand a mix of conservative, minimally invasive, and implantable solutions. Across care pathways, clinicians seek devices that balance efficacy with patient comfort and long-term durability, while procurement and payer stakeholders increasingly value demonstrable outcomes and cost-effectiveness.

Given the rapid pace of device innovation and parallel advances in materials science and digital health, manufacturers and investors must view product development through a multidisciplinary lens. Clinical evidence generation, regulatory alignment, and reimbursement pathways together create the framework for sustainable adoption. In this context, an integrated approach that couples robust clinical validation with scalable manufacturing and differentiated distribution strategies will be essential. The introduction thus frames the rest of this summary by outlining the key domains where strategic focus can unlock value, including technology differentiation, targeted end-user engagement, and resilient supply chain design.

Transformative technological, demographic, and regulatory shifts that are redefining competitive advantage and adoption pathways for urinary incontinence devices

The landscape for urinary incontinence devices is undergoing several transformative shifts driven by converging technological, demographic, and policy forces. Advances in electrical stimulation, refinement of implantable materials, and miniaturization of mechanical components are elevating device performance while improving patient comfort. Concurrently, the rise of remote monitoring and integration with mobile health platforms is enabling longitudinal adherence tracking and real-world outcome capture, which in turn supports evidence-based reimbursement discussions.

Demographically, an aging population and broader demand for quality-of-life interventions are increasing the clinical imperative for reliable, user-friendly solutions. Regulatory agencies are also adapting pathways to balance timely patient access with rigorous safety evaluation, encouraging companies to invest in post-market surveillance and real-world evidence strategies. Moreover, supply chain resilience has moved to the top of executive agendas, prompting re-evaluation of single-source dependencies and fostering nearshoring conversations. Taken together, these shifts are redefining competitive advantage: companies that pair engineering excellence with data-driven outcomes, robust regulatory planning, and supply chain agility will lead the next wave of adoption.

How tariff policy shifts enacted in 2025 are reshaping sourcing, procurement strategy, and commercialization dynamics across the urinary incontinence device value chain

The cumulative impact of United States tariff changes implemented in 2025 presents material implications for the urinary incontinence device ecosystem, particularly for manufacturers that rely on cross-border supply chains for components, finished goods, or specialized materials. Increased tariff burdens can raise input costs, compress manufacturer margins, and prompt reconsideration of sourcing strategies. In response, procurement teams are likely to pursue nearshoring, dual sourcing, and renegotiated supplier contracts to mitigate exposure and preserve margin integrity.

Beyond direct cost effects, tariffs can influence strategic decision-making around product design and material selection, nudging developers toward alternatives that reduce reliance on tariff-affected imports. Distributors and healthcare providers may face pricing adjustments, which could slow purchasing cycles in cost-sensitive segments such as long-term care facilities and ambulatory centers. At the same time, policy shifts can create opportunities for domestic manufacturing investment, with potential to shorten lead times and improve quality oversight. Clinically, stakeholders must remain vigilant to ensure that cost-driven material substitutions do not compromise device safety or performance, and that regulatory filings reflect any design or supply chain changes. In sum, tariffs act as a catalyst for broader supply chain transformation, compelling stakeholders to align procurement strategy, clinical validation, and commercial planning to preserve access and value.

Integrated segmentation insights linking device type, material selection, technology modality, patient demographics, and distribution channels to clinical adoption and commercial strategy

Key segmentation insights reveal how product design, material science, technology modality, demographic targeting, usage patterns, and channel preferences intersect to shape clinical adoption and commercial opportunity. When devices are considered by type, the market divides between External Devices and Internal Devices, with External Devices encompassing catheters, collectors and drip collectors, and penile clamps while Internal Devices include artificial urinary sphincters, pessaries, sacral nerve stimulation devices, urethral inserts, and vaginal slings. Consideration of material choices highlights the continuing relevance of latex alongside polymer-based materials and silicone, each carrying distinct implications for biocompatibility, patient comfort, and manufacturing processes.

Technological segmentation separates electrical stimulation devices from mechanical devices and surgical implants, prompting differentiated clinical trial designs and surgeon training pathways. Gender-specific approaches remain essential, as female and male patients present differing anatomical and etiological profiles that influence device selection and outcomes. Form factors that distinguish disposable from reusable products affect procurement cycles, sterilization requirements, and environmental sustainability considerations. Age-group segmentation across adults and pediatric populations requires tailored safety and usability testing. Clinical application categorization into functional incontinence, overflow incontinence, stress incontinence, and urge continence drives both product specifications and clinical endpoints. Finally, end-user distinctions among ambulatory surgical centers, homecare settings, hospitals and clinics, and long-term care facilities intersect with distribution channel preferences, including hospital pharmacies, offline pharmacies, and online sales, to define route-to-customer strategies and post-market support requirements.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine regulatory strategy, reimbursement alignment, and distribution prioritization

Regional dynamics exert a strong influence on regulatory environments, reimbursement systems, and supply chain architectures, shaping how companies prioritize investments and tailor go-to-market approaches. In the Americas, market participants face diverse payer landscapes and a high level of clinical specialization, which often necessitates clear outcome data, targeted KOL engagement, and flexible pricing frameworks. Moving across Europe, Middle East & Africa, stakeholders encounter a mosaic of regulatory requirements and reimbursement norms, where country-specific pathways and localized clinical evidence play decisive roles in adoption. In many parts of this region, partnerships with regional distributors and careful navigation of procurement cycles are critical to market entry.

Asia-Pacific presents a combination of rapid demographic change, varied regulatory maturity, and growing manufacturing capacity. The region's evolving healthcare infrastructure and rising emphasis on minimally invasive options create opportunities for novel device introductions, while local production capabilities can offer cost advantages and supply chain resilience. Across all regions, differences in end-user behavior, clinical practice patterns, and digital health readiness require that companies adopt a regionally nuanced commercial strategy that aligns product design, clinical evidence generation, and distribution partnerships with local stakeholder expectations.

Competitive dynamics, partnership models, and innovation pipelines that shape leadership trajectories and long-term differentiation in urinary incontinence therapeutics

Competitive dynamics among companies active in the urinary incontinence device arena continue to evolve, driven by product innovation, strategic partnerships, and differentiated commercialization models. Leading firms are investing in modular design strategies that enable iterative improvements while preserving regulatory continuity. Collaboration between device manufacturers and digital health providers is accelerating the development of integrated solutions that pair mechanical or implantable therapies with remote monitoring and adherence platforms, strengthening value propositions for payers and providers.

Mergers and strategic alliances remain an important route to scale, particularly where complementary portfolios or geographic footprints can be combined to optimize clinical support and distribution networks. Intellectual property portfolios centered on novel materials, stimulation algorithms, and minimally invasive delivery systems are important competitive moats. At the same time, smaller, innovation-focused entrants are contributing to an active pipeline of differentiated approaches, often leveraging focused clinical programs to prove value in niche indications before pursuing broader adoption. For commercial leaders, the interplay between product differentiation, evidence generation, and channel strategy will determine which companies achieve sustained market leadership.

Actionable priorities for device developers and commercial teams to synchronize product design, evidence generation, and supply resilience for sustained competitive advantage

Industry leaders should pursue a set of actionable priorities that align product design, clinical validation, commercial execution, and supply chain resilience to capture durable advantage. First, prioritize design-for-manufacturability and user-centric ergonomics to reduce total cost of ownership while improving patient adherence and clinician acceptance. Second, integrate robust real-world evidence plans into product lifecycles to support reimbursement negotiations and demonstrate longitudinal outcomes in diverse care settings. Third, diversify supplier bases and consider nearshoring for critical components to mitigate tariff exposure and logistical disruptions.

Fourth, develop targeted engagement programs for ambulatory surgical centers, long-term care facilities, and homecare providers, calibrating training and support to the unique workflows of each end user. Fifth, pursue strategic partnerships with digital health providers to enable remote monitoring and outcome tracking that strengthen payer value propositions. Sixth, align regulatory strategies early in development, anticipating post-market surveillance requirements and designing studies that satisfy multiple jurisdictions when feasible. Finally, embed sustainability considerations into product lifecycle planning, balancing disposable and reusable options against environmental impact and cost structures. These recommendations collectively guide leaders to make focused investments that improve adoption, manage risk, and support scalable growth.

A rigorous mixed-methods research approach that blends primary stakeholder interviews, clinical literature synthesis, and triangulated evidence validation to inform strategic decision-making

The research methodology underpinning this executive summary combined a structured review of primary clinical literature, qualitative interviews with key clinical and commercial stakeholders, and systematic analysis of regulatory and policy developments. Primary inputs included in-depth conversations with clinicians across urology and gynecology, procurement leaders from hospitals and long-term care networks, and product development experts, ensuring that technical, clinical, and commercial perspectives informed the conclusions. Secondary analysis incorporated peer-reviewed journals, regulatory guidance documents, product labeling, and company-published clinical trial summaries to validate clinical performance narratives.

Data synthesis employed triangulation techniques to reconcile divergent inputs and highlight consensus areas versus emerging debates. Segmentation frameworks were mapped to clinical pathways and end-user workflows to ensure practical relevance for commercialization decision-making. Quality control included cross-validation of interview insights against documented evidence and iterative review cycles with subject-matter experts. Where uncertainties remained, the methodology flagged topics that require further targeted study, such as long-term comparative effectiveness and durability across differing implantable materials. This approach supports confident interpretation of trends while acknowledging areas that demand deeper investigation.

A forward-looking synthesis emphasizing the strategic alignment of innovation, evidence generation, and supply resilience to maximize patient benefit and commercial success

In conclusion, the urinary incontinence device environment is at an inflection point where technological advances, changing payer expectations, and supply chain realignment converge to create both challenges and opportunities. Companies that align product innovation with pragmatic evidence strategies, resilient sourcing, and tailored regional execution will be well positioned to translate clinical capability into meaningful patient impact. Cross-functional collaboration across clinical, regulatory, and commercial teams is essential to navigate the complexities of device introduction and scale adoption across diverse care settings.

Moving forward, stakeholder attention should focus on generating high-quality outcome data, minimizing exposure to supply chain disruptions, and designing products that address specific patient and provider pain points. With these priorities in place, the sector can continue to deliver solutions that improve quality of life while meeting the rigorous expectations of modern healthcare systems. The conclusion underscores the importance of deliberate strategy and disciplined execution to capitalize on momentum and drive sustainable growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urinary Incontinence Device Market, by Device Type

  • 8.1. External Devices
    • 8.1.1. Catheters
    • 8.1.2. Collectors & Drip Collectors
    • 8.1.3. Penile Clamps
  • 8.2. Internal Devices
    • 8.2.1. Artificial Urinary Sphincters
    • 8.2.2. Pessaries
    • 8.2.3. Sacral Nerve Stimulation Devices
    • 8.2.4. Urethral Inserts
    • 8.2.5. Vaginal Slings

9. Urinary Incontinence Device Market, by Material

  • 9.1. Latex
  • 9.2. Polymer-based Materials
  • 9.3. Silicone

10. Urinary Incontinence Device Market, by Technology

  • 10.1. Electrical Stimulation Devices
  • 10.2. Mechanical Devices
  • 10.3. Surgical Implants

11. Urinary Incontinence Device Market, by Gender

  • 11.1. Female
  • 11.2. Male

12. Urinary Incontinence Device Market, by Form

  • 12.1. Disposable
  • 12.2. Reusable

13. Urinary Incontinence Device Market, by Age Group

  • 13.1. Adult
  • 13.2. Pediatrics

14. Urinary Incontinence Device Market, by Application

  • 14.1. Functional Incontinence
  • 14.2. Overflow Incontinence
  • 14.3. Stress Incontinence
  • 14.4. Urge Continence

15. Urinary Incontinence Device Market, by End User

  • 15.1. Ambulatory Surgical Centers
  • 15.2. Homecare Settings
  • 15.3. Hospitals & Clinics
  • 15.4. Long-Term Care Facilities

16. Urinary Incontinence Device Market, by Distribution Channel

  • 16.1. Offline
  • 16.2. Online

17. Urinary Incontinence Device Market, by Region

  • 17.1. Americas
    • 17.1.1. North America
    • 17.1.2. Latin America
  • 17.2. Europe, Middle East & Africa
    • 17.2.1. Europe
    • 17.2.2. Middle East
    • 17.2.3. Africa
  • 17.3. Asia-Pacific

18. Urinary Incontinence Device Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Urinary Incontinence Device Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. United States Urinary Incontinence Device Market

21. China Urinary Incontinence Device Market

22. Competitive Landscape

  • 22.1. Market Concentration Analysis, 2025
    • 22.1.1. Concentration Ratio (CR)
    • 22.1.2. Herfindahl Hirschman Index (HHI)
  • 22.2. Recent Developments & Impact Analysis, 2025
  • 22.3. Product Portfolio Analysis, 2025
  • 22.4. Benchmarking Analysis, 2025
  • 22.5. Aeroflow Inc.
  • 22.6. Amber Therapeutics
  • 22.7. Attends Healthcare Products, Inc. by Domtar Corporation
  • 22.8. Avanos Medical, Inc.
  • 22.9. Avation Medical
  • 22.10. B. Braun SE
  • 22.11. Becton, Dickinson and Company
  • 22.12. BioDerm, Inc.
  • 22.13. Boston Scientific Corporation
  • 22.14. Caldera Medical
  • 22.15. Coloplast A/S
  • 22.16. Contipi Medical
  • 22.17. ConvaTec Group PLC
  • 22.18. Essity AB
  • 22.19. Hollister Incorporated
  • 22.20. Johnson & Johnson Services Inc.
  • 22.21. Kimberly-Clark Corporation
  • 22.22. Laborie
  • 22.23. Life360 Innovation, Inc.
  • 22.24. Medtronic PLC
  • 22.25. Olympus Corporation
  • 22.26. Ontex Group NV
  • 22.27. Pelvital USA Inc.
  • 22.28. PROMEDON GmbH
  • 22.29. Styker Corporation
  • 22.30. Teleflex Incorporated
  • 22.31. Watkins-Conti Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URINARY INCONTINENCE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL URINARY INCONTINENCE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 17. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 226. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 227. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 260. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 262. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 263. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 272. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 274. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 275. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)